Login to Your Account



Pharma: Clinic Roundup


Monday, July 2, 2012

• A.P. Pharma Inc., of Redwood City, Calif., reported additional data from a Phase III trial of APF530, for chemotherapy-induced nausea and vomiting.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription